Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study

Name: Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study
Published: 2025
License: Public Domain

The Second Affiliated Hospital of Dalian Medical University · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

sclc, sclc，irinotecan liposome(ii)，ivonescimab, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study

Related documents